June 23, 2026
Osanni Bio
Osanni Bio, a development-stage therapeutics platform, raised a $190 million Series B led by Patient Square Capital.
- Round
- Series B
- Amount raised
- $190M
- Lead investor
- Patient Square Capital
- Industry
- Biotechnology Research
- Headquarters
- San Francisco, CA
- Employees
- 11-50 employees
- Website
- app.trinethire.com
- View profile →
Source: Axios